99 related articles for article (PubMed ID: 1202424)
1. Effect of adrenergic blockade on glucagon and growth hormone secretion in normal and diabetic children.
Sperling MA; Voina S
Pediatr Res; 1975 Sep; 9(9):748-52. PubMed ID: 1202424
[TBL] [Abstract][Full Text] [Related]
2. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
Rizza RA; Cryer PE; Gerich JE
J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion.
Campbell PJ; Bolli GB; Cryer PE; Gerich JE
N Engl J Med; 1985 Jun; 312(23):1473-9. PubMed ID: 2859524
[TBL] [Abstract][Full Text] [Related]
4. Characterization of adrenergic control of glucagon secretion from isolated perfused rat pancreas.
Filipponi P; Marcelli M; Nicoletti I; Pacifici R; Santeusanio F; Brunetti P
Diabete Metab; 1982 Dec; 8(4):313-8. PubMed ID: 7160520
[TBL] [Abstract][Full Text] [Related]
5. Plasma growth hormone, insulin, and glucagon responses to arginine infusion in children and adolescents with idiopathic short stature, isolated growth hormone deficiency, panhypopituitarism, and anorexia nervosa.
Sizonenko PC; Rabinovitch A; Schneider P; Paunier L; Wollheim CB; Zahnd G
Pediatr Res; 1975 Sep; 9(9):733-8. PubMed ID: 1105371
[TBL] [Abstract][Full Text] [Related]
6. Dopamine during alpha- or beta-adrenergic blockade in man. Hormonal, metabolic, and cardiovascular effects.
Lorenzi M; Karam JH; Tsalikian E; Bohannon NV; Gerich JE; Forsham PH
J Clin Invest; 1979 Feb; 63(2):310-7. PubMed ID: 34629
[TBL] [Abstract][Full Text] [Related]
7. The effect of adrenergic blockade on the glucagon responses to starvation and hypoglycemia in man.
Walter RM; Dudl RJ; Palmer JP; Ensinck JW
J Clin Invest; 1974 Nov; 54(5):1214-20. PubMed ID: 4153713
[TBL] [Abstract][Full Text] [Related]
8. Adrenergic blockade alters glucose kinetics during exercise in insulin-dependent diabetics.
Simonson DC; Koivisto V; Sherwin RS; Ferrannini E; Hendler R; Juhlin-Dannfelt A; DeFronzo RA
J Clin Invest; 1984 Jun; 73(6):1648-58. PubMed ID: 6327767
[TBL] [Abstract][Full Text] [Related]
9. Adrenergic modulation of pancreatic glucagon secretion in man.
Gerich JE; Langlois M; Noacco C; Schneider V; Forsham PH
J Clin Invest; 1974 May; 53(5):1441-6. PubMed ID: 4825234
[TBL] [Abstract][Full Text] [Related]
10. Adrenergic receptor control mechanism for growth hormone secretion.
Blackard WG; Heidingsfelder SA
J Clin Invest; 1968 Jun; 47(6):1407-14. PubMed ID: 5653218
[TBL] [Abstract][Full Text] [Related]
11. Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.
Giugliano D; Luyckx AS; Lefebvre PJ
Diabete Metab; 1980 Mar; 6(1):39-46. PubMed ID: 6989660
[TBL] [Abstract][Full Text] [Related]
12. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man.
Rizza RA; Cryer PE; Haymond MW; Gerich JE
J Clin Invest; 1980 Mar; 65(3):682-9. PubMed ID: 6243675
[TBL] [Abstract][Full Text] [Related]
13. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
[TBL] [Abstract][Full Text] [Related]
14. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
Saccà L; Sherwin R; Hendler R; Felig P
J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
[TBL] [Abstract][Full Text] [Related]
15. Serum insulin, pancreatic glucagon and growth hormone levels in response to intravenous infusion of L-arginine in patients with recently detected juvenile diabetes.
Lawecki J; Symonides-Lawecka A; Rogala H
Pol Med Sci Hist Bull (1973); 1976; 15(2):177-82. PubMed ID: 959042
[TBL] [Abstract][Full Text] [Related]
16. Effect of adrenergic blocking agents on plasma gastrin and secretin levels in man.
Seino S; Seino Y; Taminato T; Mori K; Matsukura S; Yawata M; Imura H
Am J Gastroenterol; 1980 Feb; 73(2):137-40. PubMed ID: 6104918
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of gastric glucagon secretion by epinephrine administration in dogs.
Blázquez E; Muñoz-Barragán L
Rev Esp Fisiol; 1990 Sep; 46(3):231-6. PubMed ID: 2091148
[TBL] [Abstract][Full Text] [Related]
18. The effect of adrenergic receptor blockade on the exercise-induced serum growth hormone rise in normals and juvenile diabetics.
Hansen AP
J Clin Endocrinol Metab; 1971 Nov; 33(5):807-12. PubMed ID: 4399438
[No Abstract] [Full Text] [Related]
19. Adrenergic modulation of potassium metabolism during exercise in normal and diabetic humans.
Castellino P; Simonson DC; DeFronzo RA
Am J Physiol; 1987 Jan; 252(1 Pt 1):E68-76. PubMed ID: 3544863
[TBL] [Abstract][Full Text] [Related]
20. Adrenergic regulation of glucagon and insulin secretion during immobilization stress in normal and spontaneously diabetic BB rats.
Nakhooda AF; Sole MJ; Marliss EB
Am J Physiol; 1981 Apr; 240(4):E373-8. PubMed ID: 7013496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
